Deals Shaping The Medical Industry, November 2020
Derived from Biomedtracker, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
Executive Summary
This month’s column covers deals announced in November 2020. Data provided by Biomedtracker.
You may also be interested in...
US FDA, NIST Join Forces To Improve Manufacturing, Prevent Drug And Device Shortages
The focus on innovative manufacturing will also include a new clearinghouse to share info about advanced manufacturing technology within the US agency’s device center.
AdvaMed: Medtech Industry Wants Seat At Biden’s Coronavirus Response Table
The largest medical device lobby group in the US says it’s open to the administration’s decision to invoke the Defense Production Act to boost testing and PPE production, but wants to be consulted on how to implement it.
Warnings Note Disease Treatment Studies Placed Too Close To Supplements For US FDA’s Comfort
Dietary ingredients identified in recent FDA warning letters as linked to disease claims by marketers directing customers to scientific literature include omega-3 fatty acid, ginkgo biloba, glucosamine curcumin and vitamin D.
Need a specific report? 1000+ reports available
Buy Reports